NewAmsterdam Pharma Company N.V./$NAMS
About NewAmsterdam Pharma Company N.V.
Ticker
Industry
Employees
NAMS Metrics
$2.6B
-
-$2.21
0.07
-
Price and volume
Market cap
$2.6B
Beta
0.07
52-week high
$26.95
52-week low
$15.19
Average daily volume
1.1M
Financial strength
Current ratio
10.614
Quick ratio
10.371
Long term debt to equity
0.07
Total debt to equity
0.134
Management effectiveness
Return on equity (TTM)
-47.37%
Valuation
Price to revenue (TTM)
65.938
Price to book
5.98
Price to tangible book (TTM)
5.99
Price to free cash flow (TTM)
-14.307
Growth
Revenue change (TTM)
78.77%
Earnings per share change (TTM)
-17.38%
NAMS News
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
FAQs
What’s the current market cap for NewAmsterdam Pharma Company N.V. stock?
What is the P/E ratio for NewAmsterdam Pharma Company N.V. stock?
Does NewAmsterdam Pharma Company N.V. stock pay dividends?
No, NewAmsterdam Pharma Company N.V. (NAMS) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next NewAmsterdam Pharma Company N.V. dividend payment date?
NewAmsterdam Pharma Company N.V. (NAMS) stock does not pay dividends to its shareholders.
What is the beta indicator for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. (NAMS) has a beta rating of 0.07. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.